Study Title
CONNECT1903: A pilot and surgical study of larotrectinib for treatment of children with newly-diagnosed high-grade glioma with NTRK fusion
Protocol ID
CONNECT1903
Condition/s
High Grade Glioma (HGG)
Diffuse Intrinsic Pontine Glioma (DIPG)
Diffuse Intrinsic Pontine Glioma (DIPG)
Diagnosis Stage
New diagnosis
Location
NSW, QLD, VIC, WA, NZ
Sponsor
Australian and New Zealand Children's Haematology Oncology Group
Nationwide Children's Hospital
Nationwide Children's Hospital
Links
Trial Status
Open
Sites
Perth Children's Hospital
Sydney Children's Hospital
Queensland Children's Hospital
Starship Children's Hospital, New Zealand
The Royal Children's Hospital
Sydney Children's Hospital
Queensland Children's Hospital
Starship Children's Hospital, New Zealand
The Royal Children's Hospital
Study Type
Treatment
Phase
Pilot
Age Eligibility
up to 21 years
International registry ID's
NCT04655404
| Study Title | CONNECT1903: A pilot and surgical study of larotrectinib for treatment of children with newly-diagnosed high-grade glioma with NTRK fusion |
|---|---|
| Protocol ID | CONNECT1903 |
| Disease (Sub Disease) | High Grade Glioma (HGG) Diffuse Intrinsic Pontine Glioma (DIPG) |
| Diagnosis Stage | New diagnosis |
| Location | NSW / QLD / VIC / WA / NZ |
| Sponsor | Australian and New Zealand Children's Haematology Oncology Group/ Nationwide Children's Hospital |
| Links | https://clinicaltrials.gov/ct2/show/NCT04655404 |
| Trial Status | Open |
| Trial Open Date | 08/04/2021 |
| Sites | Perth Children's Hospital / Sydney Children's Hospital / Queensland Children's Hospital/ Starship Children's Hospital, New Zealand / The Royal Children's Hospital |
| Study Type | Treatment |
| Phase | Pilot |
| Age Eligibility | up to 21 years |
| International registry ID's | NCT04655404 |